Accelerated immunosenescence in SLE: current evidence and clinical translation

• by Qingshuang Li, Wei Zhang, Yulan Chen, Jing Du

• June 17, 2026

FDA Approves Atacicept for IgA Nephropathy

The approval was based on reduced proteinuria, and an ongoing trial is required to determine whether atacicept slows long-term kidney function decline.

• by Kathryn Wighton

• July 7, 2026

• 3 min

Editorial: Community series in towards precision medicine for immune-mediated disorders: advances in using big data and artificial intelligence to understand heterogeneity in inflammatory responses, volume III

• by Xu-jie Zhou, Le-ting Zhou, Celine C. Berthier, Swapan K. Nath

• June 2, 2026

Diplopia as the herald of fulminant myocarditis in undifferentiated connective tissue disease: a case report

• by Yongqi Chen, Yinping Li, Rui Zhang, Xiaokang Liu, Jingwen Zhang, Ning Zhai, Hanheng Zuo, Xueying Chen

• June 4, 2026